Publications4 June 2021/in News/by Jan GroenView some publications in which DGr Pharma is involved… Bradykinin Challenge Provides Surrogate Endpoints For Hereditary Angioedema TreatmentUsing Bradykinin-B2-Receptor Antagonists PHA-022121, a Selective Bradykinin-B2-Receptor Antagonist, Is Safe and Shows Rapid Oral Bioavailability in Humans https://www.dgrpharma.com/cms19/wp-content/uploads/2019/05/header-pharma-def.jpg 912 1900 Jan Groen https://www.dgrpharma.com/cms19/wp-content/uploads/2019/04/logo-Pharma-149x60.png Jan Groen2021-06-04 08:36:022025-02-24 14:28:11Publications
